Esperion Therapeutics, Inc. (27)

Browse by Contract Category

Contracts

Employment Agreement, dated March 1, 2022, by and between Esperion Therapeutics, Inc. and Eric Warren (Filed With SEC on March 1, 2022)
Form of Warrant to Purchase Common Stock (Filed With SEC on December 7, 2021)
License and Collaboration Agreement, by and between the Registrant and Daiichi Sankyo Company, Limited dated April 26, 2021 (Filed With SEC on August 3, 2021)
Agreement dated May 15, 2021 by and between Esperion Therapeutics, Inc. and Tim M. Mayleben (Filed With SEC on May 17, 2021)
Employment Agreement, dated January 1, 2022, by and between Esperion Therapeutics, Inc. and Benjamin O. Looker (Filed With SEC on January 4, 2022)
Underwriting Agreement, dated December 2, 2021, between Esperion Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on December 7, 2021)
Exchange Agreement, dated October 22, 2021, by and between Esperion Therapeutics, Inc. and the Holders (Filed With SEC on October 25, 2021)
Amended and Restated Employment Agreement by and between the Registrant and Sheldon Koenig dated May 14, 2021 (Filed With SEC on August 3, 2021)
Employment Agreement, dated June 28, 2021, by and between Esperion Therapeutics, Inc. and JoAnne Foody (Filed With SEC on June 28, 2021)
2nd Amendment to the License and Collaboration Agreement by and between the Registrant and Daiichi Sankyo Europe GMBH dated March 19, 2021 (Filed With SEC on May 4, 2021)
Amendment No. 2 to Revenue Interest Purchase Agreement dated April 26, 2021 between the Company, Eiger Partners II LP and Eiger III SA LLC (Filed With SEC on April 26, 2021)
Employment Agreement by and between the Registrant and Sheldon Koenig effective December 15, 2020 (Filed With SEC on February 23, 2021)
Employment Agreement by and between the Registrant and Ashley Hall effective August 28, 2015 (Filed With SEC on February 23, 2021)
Amendment No. 1 to the Revenue Interest Purchase Agreement, dated November 11, 2020, by and among the Company, the purchasers from time to time party thereto and Eiger III SA LLC,... (Filed With SEC on February 23, 2021)
Forward Stock Purchase Confirmation, dated November 11, 2020, between Esperion Therapeutics, Inc. and Morgan Stanley & Co. LLC (Filed With SEC on November 16, 2020)
Form of Capped Call Confirmation (Filed With SEC on November 16, 2020)
Indenture, dated as of November 16, 2020, between Esperion Therapeutics, Inc. and U.S. Bank National Association (Filed With SEC on November 16, 2020)
1st Amendment to the License and Collaboration Agreement by and between the Registrant and Daiichi Sankyo Europe GMBH dated June 18, 2020 (Filed With SEC on August 10, 2020)
License and Collaboration Agreement by and between the Registrant and Otsuka Pharmaceutical Co., Ltd. dated April 17, 2020 (Filed With SEC on August 10, 2020)
Esperion Therapeutics, Inc. 2020 Employee Stock Purchase Plan, as amended (Filed With SEC on August 10, 2020)
Esperion Therapeutics, Inc. 2020 Employee Stock Purchase Plan (Filed With SEC on May 29, 2020)
First Amendment to 2017 Inducement Equity Plan (Filed With SEC on February 27, 2020)
Description of Registrant's Securities (Filed With SEC on February 27, 2020)
Revenue Interest Purchase Agreement by and between the Company, Eiger III SA LLC, and the Purchasers named therein, dated June 26, 2019 (Filed With SEC on June 26, 2019)
Employment Agreement by and between the Registrant and Mark Glickman dated March 14, 2018 (Filed With SEC on February 28, 2019)
License and Collaboration Agreement by and between Daiichi Sankyo Europe GmbH and the Company, dated as of January 2, 2019 (Filed With SEC on February 28, 2019)
Employment Agreement by and between the Registrant and Richard B. Bartram dated May 14, 2015 (Filed With SEC on February 28, 2019)